John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.
John Rinn on Discovering Drugs Based on Long Non-Coding RNA
Previous
Previous
Corus Radiothon in support of the Stollery Children's Hospital: Sam’s Story
Next
Next